Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Hamamoto

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
Drug Discoveries & Therapeutics|July 8, 2021
Applying the silkworm model for the search of immunosuppressantsAtsushi Miyashita, Hiroshi Hamamoto, Kazuhisa Sekimizu
Plos One|March 4, 2014
Establishment of a bacterial infection model using the European honeybee, Apis mellifera LKenichi Ishii, Hiroshi Hamamoto, Kazuhisa Sekimizu
Drug Discoveries & Therapeutics|April 14, 2015
Studies of host-pathogen interactions and immune-related drug development using the silkworm: interdisciplinary immunology, microbiology, and pharmacology studiesKenichi Ishii, Hiroshi Hamamoto, Kazuhisa Sekimizu
Drug Discoveries & Therapeutics|July 20, 2016
Menaquinone as a potential target of antibacterial agentsAtmika Paudel, Hiroshi Hamamoto, Suresh Panthee, et al.
The Journal of Biological Chemistry|October 20, 2007
Activation of the silkworm cytokine by bacterial and fungal cell wall components via a reactive oxygen species-triggered mechanismKenichi Ishii, Hiroshi Hamamoto, Manabu Kamimura, et al.
Frontiers in Microbiology|March 23, 2017
Advantages of the Silkworm As an Animal Model for Developing Novel Antimicrobial AgentsSuresh Panthee, Atmika Paudel, Hiroshi Hamamoto, et al.
Pharmaceutical Biology|March 4, 2017
In vitro antibacterial activity and in vivo therapeutic effect of Sesbania grandiflora in bacterial infected silkwormsPimporn Anantaworasakul, Hiroshi Hamamoto, Kazuhisa Sekimizu, et al.
Archives of Microbiology|August 20, 2016
Lysobacter species: a potential source of novel antibioticsSuresh Panthee, Hiroshi Hamamoto, Atmika Paudel, et al.
RSC Advances|May 11, 2022
GPI0363 inhibits the interaction of RNA polymerase with DNA in <i>Staphylococcus aureus</i>Atmika Paudel, Suresh Panthee, Hiroshi Hamamoto, et al.
JACS Au|November 28, 2025
Impact of Tryptophan Positional Isomerism on Physicochemical and Biological Properties: A Case Study Using Gramicidin A AnalogsTakahiro Migita, Hiroaki Itoh, Hiroshi Hamamoto, et al.
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
Drug Discoveries & Therapeutics|July 8, 2021
Applying the silkworm model for the search of immunosuppressantsAtsushi Miyashita, Hiroshi Hamamoto, Kazuhisa Sekimizu
Plos One|March 4, 2014
Establishment of a bacterial infection model using the European honeybee, Apis mellifera LKenichi Ishii, Hiroshi Hamamoto, Kazuhisa Sekimizu
Drug Discoveries & Therapeutics|April 14, 2015
Studies of host-pathogen interactions and immune-related drug development using the silkworm: interdisciplinary immunology, microbiology, and pharmacology studiesKenichi Ishii, Hiroshi Hamamoto, Kazuhisa Sekimizu
Drug Discoveries & Therapeutics|July 20, 2016
Menaquinone as a potential target of antibacterial agentsAtmika Paudel, Hiroshi Hamamoto, Suresh Panthee, et al.
The Journal of Biological Chemistry|October 20, 2007
Activation of the silkworm cytokine by bacterial and fungal cell wall components via a reactive oxygen species-triggered mechanismKenichi Ishii, Hiroshi Hamamoto, Manabu Kamimura, et al.
Frontiers in Microbiology|March 23, 2017
Advantages of the Silkworm As an Animal Model for Developing Novel Antimicrobial AgentsSuresh Panthee, Atmika Paudel, Hiroshi Hamamoto, et al.
Pharmaceutical Biology|March 4, 2017
In vitro antibacterial activity and in vivo therapeutic effect of Sesbania grandiflora in bacterial infected silkwormsPimporn Anantaworasakul, Hiroshi Hamamoto, Kazuhisa Sekimizu, et al.
Archives of Microbiology|August 20, 2016
Lysobacter species: a potential source of novel antibioticsSuresh Panthee, Hiroshi Hamamoto, Atmika Paudel, et al.
RSC Advances|May 11, 2022
GPI0363 inhibits the interaction of RNA polymerase with DNA in <i>Staphylococcus aureus</i>Atmika Paudel, Suresh Panthee, Hiroshi Hamamoto, et al.
JACS Au|November 28, 2025
Impact of Tryptophan Positional Isomerism on Physicochemical and Biological Properties: A Case Study Using Gramicidin A AnalogsTakahiro Migita, Hiroaki Itoh, Hiroshi Hamamoto, et al.
Pageof 14